Pharma Launch Forecasting: From Static Annual Models to Real-Time Commercial Intelligence
Background: A global specialty pharmaceutical company was approaching the launch of a new chronic-therapy asset in a market characterized by heavy competition. The compound had strong clinical differ ...
Evidence Without Context: Why Advanced Analytics Still Miss Commercial Reality
Advanced analytics has transformed how life sciences teams generate evidence. We can analyze massive datasets, model future markets, and simulate treatment pathways with remarkable precision. Yet desp ...
Market Access Doesn’t Begin After Approval. It Begins with Evidence
Why the most successful commercial launches are built long before reimbursement discussions begin For years, market access has been treated as a milestone. From developing the therapy, to completing t ...